Sema4 Holdings Corp (SMFR) Stock

DelistedNasdaq: SMFRSema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data.

0.34
Final close · Mar 10, 2023

SMFR is no longer traded. Sema4 Holdings was delisted from the Nasdaq in March 2023.

Prices on this page are historical; the last trade was March 10, 2023 at $0.34.

Sema4 Holdings stock price history

Split-adjusted closes, 2020–2023

SMFR final trading statistics

Final close
$0.34
Final trading day
Mar 10, 2023
Market cap at delisting
$132.71M
Shares outstanding
386.80M
Final 52-week range
$0.22 – $3.28
Avg. volume (final 3 mo.)
3,610,839
All-time high (split-adj.)
$851.73 · Feb 2021
All-time low (split-adj.)
$7.40 · Dec 2022
Return since IPO
-96.5%
Beta
1.87
Book value / share
$1.47
Price / book
0.23
Final 52 wk
0.223.28

Sema4 Holdings earnings per share

Earnings per share

Sema4 Holdings revenue & net income

RevenueNet income

Sema4 Holdings annual financials

Sema4 Holdings Corp revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$234.69M-$549.0M-$1.59
FY2021$212.19M-$245.4M-$1.29
FY2020$179.32M-$192.2K-$0.00
FY2019$196.17M-$29.7M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Sema4 Holdings Corp

Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.

Sema4 Holdings stock FAQ

What happened to Sema4 Holdings stock?

Sema4 Holdings stock was delisted from the Nasdaq. Its final close was $0.34 on March 10, 2023.

Is SMFR stock still trading?

No. SMFR was delisted from the Nasdaq in March 2023 and no longer trades on a U.S. exchange.

What was the last price of SMFR stock?

SMFR closed at $0.34 on its final trading day, March 10, 2023, for a market value of about $132.71M.

What were Sema4 Holdings's revenue and earnings in its last full fiscal year?

Sema4 Holdings reported revenue of $234.69M and net income of -$549.0M in fiscal 2022, its last full year as a public company.

When did Sema4 Holdings go public?

Sema4 Holdings Corp stock began trading on November 4, 2020.

Healthcare Providers & Services stocks to research

All Healthcare stocks →